Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia
- 1 May 2022
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 22 (6) , 640-649
Abstract
Background: Specific Antibody Deficiency (SAD) is a primary immunodefi-ciency disease (PID) characterized by the occurrence of recurrent infections and inade-quate antibody response to polysaccharide new antigens. Objective: This study aims to determine the titer of specific antibodies against unconju-gated 23-valent pneumococcal polysaccharide vaccine (PPSV-23), the presence of SAD, and its association with clinical and laboratory findings in Ataxia-telangiectasia (A-T) and selective immunoglobulin A deficiency (SIgAD) patients. Methods: 32 A-T patients and 43 SIgAD patients were included in this cross-sectional study. Samples of the patients were obtained before and three weeks after vaccination with PPSV-23. Specific immunoglobulin G (IgG) directed towards pneumococcal capsular an-tigen and specific antibodies against whole pneumococcal antigens was measured. Results: Comparison of the response to vaccination revealed that 81.3% of A-T patients and 18.6% of the SIgAD patients had an inadequate response to PPSV-23 (p<0.001). The prevalence of recurrent infection (p=0.034) and pneumonia (p=0.003) in SIgAD patients was significantly higher in non-responders than responders. Likewise, the number of mar-ginal zone B cells (p=0.037), transitional B cells (p=0.019), plasmablasts (p=0.019), CD8+ naïve T cells (p=0.036), and percentage of CD8+ T cells (p=0.047), switched memory B cells (SMB) (p=0.026) and immunoglobulin M (IgM) memory B cells (p=0.022) in SIgAD patients were significantly lower in non-responder group than responder group. In con-trast, the percentage of CD4 T+ cells in A-T patients was lower in the non-responder group than responders (p=0.035). Conclusion: SAD is more frequent in A-T patients than SIgAD patients. The role of SMB and T cells should not be underestimated in SAD.Keywords
Funding Information
- vice chancellor for research, Tehran University of Medical Sciences (38994)
This publication has 60 references indexed in Scilit:
- Pneumonia immunization in older adults: review of vaccine effectiveness and strategiesClinical Interventions in Aging, 2012
- Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & ImmunologyJournal of Allergy and Clinical Immunology, 2012
- Marginal Zone B-Cells, a Gatekeeper of Innate ImmunityFrontiers in Immunology, 2011
- Selective IgA DeficiencyJournal of Clinical Immunology, 2010
- Pathogenesis, Diagnosis, and Management of Primary Antibody Deficiencies and InfectionsClinical Microbiology Reviews, 2009
- Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated geneClinical and Experimental Immunology, 2008
- The kinetics and phenotype of the human B‐cell response following immunization with a heptavalent pneumococcal‐CRM197 conjugate vaccineImmunology, 2006
- Resposta a antígenos polissacarídicos em pacientes com ataxia-telangiectasiaJornal de Pediatria, 2006
- THE GENETIC DEFECT IN ATAXIA-TELANGIECTASIAAnnual Review of Immunology, 1997
- Patients with IgG subclass and/or selective antibody deficiency to polysaccharide antigens: Initiation of a controlled clinical trial of intravenous immune globulinJournal of Allergy and Clinical Immunology, 1989